Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) — The “Global Structural Heart Devices Market Analysis & Forecast to 2024-2034” report has been added to ResearchAndMarkets.com’s offering.
Driven by increasing prevalence of cardiovascular diseases and technological advancements, the global structural heart devices market is projected to experience significant expansion, reaching USD 18.77 billion by 2034.
This rapidly evolving sector, marked by a compound annual growth rate (CAGR) of 9.48% from 2024 to 2034, is being propelled forward by rising demands for minimally invasive procedures and government initiatives aimed at cardiovascular disease management.
The rise in R&D activities, coupled with technological innovation in device design and materials, has given rise to a new wave of advanced solutions for structural heart disease, making way for a robust market landscape. In particular, heart valve devices have emerged as the leading product segment, generating the highest revenue within the market space due to substantial product approvals and a surge in novel therapeutic offerings.
Significant Market Segments Show Promising Growth Outlook
Fuelled by enhancements in medical technology and increased adoption rates, repair procedures continue to dominate the market in terms of revenue generation. Innovations like the MitraClip system underscore the market’s commitment to refining minimally invasive approaches. Concurrently, the replacement procedure segment is anticipated to exhibit the fastest CAGR throughout the forecast period, supported by advancements in valve replacement technologies.
Pivotal indicators such as aortic valvular disease have steered the market with significant revenue contributions. However, pulmonary valvular disease is expected to be the fastest-growing segment, spurred by new system launches and increasing procedural volumes.
Hospitals remain essential end users, with their state-of-the-art medical facilities and expert surgical teams driving revenue growth. Nonetheless, ambulatory surgical centers are forecast to soar at the fastest CAGR, as they embrace modern technologies and patient preferences move towards outpatient care settings.
Geographical Highlights: North America Leads While Asia Pacific Shows Impressive Growth Trajectory
In terms of geographical distribution, North America is projected to maintain its revenue lead, supported by extensive healthcare spending and burgeoning R&D activities. Innovations such as 3D-GNC technology for heart navigation are emblematic of the region’s commitment to cutting-edge healthcare solutions. The Asia Pacific region is on track to chart the most rapid growth rate, spurred by a burgeoning elderly population, rising incidence of cardiac disorders, and increased access to advanced structural heart devices.
- Occluders & Delivery Systems
- Heart Valve Devices
- Annuloplasty Rings
- Repair Procedures
- Replacement Procedures
- Atrial Septal Defects
- Pulmonary Valvular Disease
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
The regional market outlook is complemented by a robust analysis that spans the United States and Canada within North America, as well as an in-depth exploration of European markets including Germany, France, and the UK. The Asia Pacific report segments detail the contributions of China, Japan, India, and additional nations within the region, revealing a dynamic and varied structural heart devices landscape.
Implications for Global Healthcare and Patient Outcomes
The growth of the global structural heart devices market is indicative of a broader trend towards improving cardiovascular care and patient outcomes through innovative medical devices and procedures. As the market continues to evolve, it is likely to have a transformative impact on healthcare delivery, patient care standards, and the management of structural heart diseases worldwide.
This analysis provides a comprehensive view of the current state and future potential of the structural heart devices market, highlighting the importance of technological advancement and the increasing prevalence of heart conditions that require immediate attention. Stakeholders in the healthcare sector and interested parties are encouraged to explore the detailed findings of this report, which elucidates the trajectory of one of the most crucial health markets in the coming decade.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 – 2034 |
| Estimated Market Value (USD) in 2023 | $6.93 Billion |
| Forecasted Market Value (USD) by 2034 | $18.77 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
Report Segmentation: Structural Heart Devices Market
By Product
- Occluders & Delivery Systems
- Annuloplasty Rings
- Heart Valve Devices
- Other
By Procedure
- Repair Procedure
- Left Atrial Appendage Closure (LAAC)
- Mitral Repair
- Replacement Procedure
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)))
By Indication
- Pulmonary Valvular Disease
- Atrial Septal Defects
- Patent Foramen Ovale
- Mitral Valvular Disease
- Aortic Valvular Disease
- Patent Ductus Arteriosus
- Ventricular Septal Defects
- Others
By End-user
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
Companies Profiled
- Abbott Laboratories
- Medical Technology Est.
- Biomerics
- Comed BV
- CardioKinetix
- Edwards Lifesciences Corporation
- Cryolife Inc.
- Medtronic plc
- Braile Biomedica
- Micro Interventional Devices Inc.
- Boston Scientific Corporation
- LivaNova PLC
- St. Jude Medical Inc.
- JenaValve Technology Inc.
- ST. JUDE MEDICAL
For more information about this report visit https://www.researchandmarkets.com/r/fwssuz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Structural Heart Devices Market
